APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acute Kidney Injury Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Acute Kidney Injury Drugs Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchAcute Kidney Injury Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Acute Kidney Injury Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Acute Kidney Injury Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acute Kidney Injury Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Acute Kidney Injury Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Acute Kidney Injury Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acute Kidney Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acute Kidney Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acute Kidney Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acute Kidney Injury Drugs include Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Quark Pharmaceuticals, Baxter International, LG Chem, Asahi Kasei Medical and Angion Biomedica Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acute Kidney Injury Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acute Kidney Injury Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acute Kidney Injury Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acute Kidney Injury Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Acute Kidney Injury Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acute Kidney Injury Drugs Market by Company

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen AG

Quark Pharmaceuticals

Baxter International

LG Chem

Asahi Kasei Medical

Angion Biomedica Corp

Acute Kidney Injury Drugs Segment by Type

Intrinsic Acute Kidney Injury

Postrenal Acute Kidney Injury

Prerenal Acute Kidney Injury

Others

Acute Kidney Injury Drugs Segment by Application

Hospital

Clinic

Acute Kidney Injury Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Kidney Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acute Kidney Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Kidney Injury Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acute Kidney Injury Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Acute Kidney Injury Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intrinsic Acute Kidney Injury Table 2. Major Company of Postrenal Acute Kidney Injury Table 3. Major Company of Prerenal Acute Kidney Injury Table 4. Major Company of Others Table 5. Global Acute Kidney Injury Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 7. Global Acute Kidney Injury Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Acute Kidney Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Acute Kidney Injury Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Acute Kidney Injury Drugs Price by Type (2021-2026) & (US$/unit) Table 11. Global Acute Kidney Injury Drugs Sales by Type (2027-2032) & (k units) Table 12. Global Acute Kidney Injury Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Acute Kidney Injury Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Acute Kidney Injury Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Acute Kidney Injury Drugs Price by Type (2027-2032) & (US$/unit) Table 16. North America Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 17. North America Acute Kidney Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 19. Europe Acute Kidney Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Acute Kidney Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 23. Latin America Acute Kidney Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Acute Kidney Injury Drugs Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Acute Kidney Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Acute Kidney Injury Drugs Industry Trends Table 27. Acute Kidney Injury Drugs Industry Drivers Table 28. Acute Kidney Injury Drugs Industry Opportunities and Challenges Table 29. Acute Kidney Injury Drugs Industry Restraints Table 30. Global Acute Kidney Injury Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Acute Kidney Injury Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Acute Kidney Injury Drugs Sales by Company (2021-2026) & (k units) Table 33. Global Acute Kidney Injury Drugs Sales Share by Company (2021-2026) Table 34. Global Acute Kidney Injury Drugs Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Acute Kidney Injury Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Acute Kidney Injury Drugs Major Company Production Sites and Headquarters Table 37. Global Acute Kidney Injury Drugs Company, Product Type & Application Table 38. Global Acute Kidney Injury Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Acute Kidney Injury Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Acute Kidney Injury Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Acute Kidney Injury Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Acute Kidney Injury Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Acute Kidney Injury Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Acute Kidney Injury Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Acute Kidney Injury Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Acute Kidney Injury Drugs Sales by Region (2027-2032) & (k units) Table 48. Global Acute Kidney Injury Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Acute Kidney Injury Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Acute Kidney Injury Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Acute Kidney Injury Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Acute Kidney Injury Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Acute Kidney Injury Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Acute Kidney Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Acute Kidney Injury Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Acute Kidney Injury Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Acute Kidney Injury Drugs Sales by Application (2027-2032) & (k units) Table 59. Global Acute Kidney Injury Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Acute Kidney Injury Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Acute Kidney Injury Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Acute Kidney Injury Drugs Price by Application (2027-2032) & (US$/unit) Table 63. North America Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 64. North America Acute Kidney Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 66. Europe Acute Kidney Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Acute Kidney Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 70. Latin America Acute Kidney Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Acute Kidney Injury Drugs Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Acute Kidney Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Fresenius Medical Care AG & Co. KGaA Company Information Table 74. Fresenius Medical Care AG & Co. KGaA Business Overview Table 75. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolio Table 77. Fresenius Medical Care AG & Co. KGaA Recent Development Table 78. B. Braun Melsungen AG Company Information Table 79. B. Braun Melsungen AG Business Overview Table 80. B. Braun Melsungen AG Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolio Table 82. B. Braun Melsungen AG Recent Development Table 83. Quark Pharmaceuticals Company Information Table 84. Quark Pharmaceuticals Business Overview Table 85. Quark Pharmaceuticals Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolio Table 87. Quark Pharmaceuticals Recent Development Table 88. Baxter International Company Information Table 89. Baxter International Business Overview Table 90. Baxter International Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Baxter International Acute Kidney Injury Drugs Product Portfolio Table 92. Baxter International Recent Development Table 93. LG Chem Company Information Table 94. LG Chem Business Overview Table 95. LG Chem Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. LG Chem Acute Kidney Injury Drugs Product Portfolio Table 97. LG Chem Recent Development Table 98. Asahi Kasei Medical Company Information Table 99. Asahi Kasei Medical Business Overview Table 100. Asahi Kasei Medical Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolio Table 102. Asahi Kasei Medical Recent Development Table 103. Angion Biomedica Corp Company Information Table 104. Angion Biomedica Corp Business Overview Table 105. Angion Biomedica Corp Acute Kidney Injury Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolio Table 107. Angion Biomedica Corp Recent Development Table 108. North America Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 109. North America Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 110. North America Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026) Table 111. North America Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (k units) Table 112. North America Acute Kidney Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 113. North America Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Acute Kidney Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Acute Kidney Injury Drugs Market Share by Country (2021-2026) Table 116. North America Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Acute Kidney Injury Drugs Market Share Forecast by Country (2027-2032) Table 118. Europe Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. Europe Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 120. Europe Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026) Table 121. Europe Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (k units) Table 122. Europe Acute Kidney Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Acute Kidney Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Acute Kidney Injury Drugs Market Share by Country (2021-2026) Table 126. Europe Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Acute Kidney Injury Drugs Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 130. Asia-Pacific Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (k units) Table 132. Asia-Pacific Acute Kidney Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Acute Kidney Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Acute Kidney Injury Drugs Market Share by Country (2021-2026) Table 136. Asia-Pacific Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Acute Kidney Injury Drugs Market Share Forecast by Country (2027-2032) Table 138. Latin America Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Latin America Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 140. Latin America Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026) Table 141. Latin America Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (k units) Table 142. Latin America Acute Kidney Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Acute Kidney Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Acute Kidney Injury Drugs Market Share by Country (2021-2026) Table 146. Latin America Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Acute Kidney Injury Drugs Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Acute Kidney Injury Drugs Sales by Country (2021-2026) & (k units) Table 150. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032) & (k units) Table 152. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Acute Kidney Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Acute Kidney Injury Drugs Market Share by Country (2021-2026) Table 156. Middle East and Africa Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Acute Kidney Injury Drugs Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Acute Kidney Injury Drugs Distributors List Table 161. Acute Kidney Injury Drugs Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Acute Kidney Injury Drugs Image Figure 2. Global Acute Kidney Injury Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acute Kidney Injury Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Acute Kidney Injury Drugs Sales (2021-2032) & (k units) Figure 5. Intrinsic Acute Kidney Injury Image Figure 6. Global Intrinsic Acute Kidney Injury Sales YoY Growth (2021-2032) & (k units) Figure 7. Postrenal Acute Kidney Injury Image Figure 8. Global Postrenal Acute Kidney Injury Sales YoY Growth (2021-2032) & (k units) Figure 9. Prerenal Acute Kidney Injury Image Figure 10. Global Prerenal Acute Kidney Injury Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Acute Kidney Injury Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Acute Kidney Injury Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Acute Kidney Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Acute Kidney Injury Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Acute Kidney Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Acute Kidney Injury Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Acute Kidney Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Acute Kidney Injury Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Acute Kidney Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Acute Kidney Injury Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Acute Kidney Injury Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Acute Kidney Injury Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Acute Kidney Injury Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Acute Kidney Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Acute Kidney Injury Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Acute Kidney Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Acute Kidney Injury Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Acute Kidney Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Acute Kidney Injury Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Acute Kidney Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Acute Kidney Injury Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Acute Kidney Injury Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Acute Kidney Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Acute Kidney Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Acute Kidney Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Acute Kidney Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Acute Kidney Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Acute Kidney Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Acute Kidney Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Acute Kidney Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Acute Kidney Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Acute Kidney Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Acute Kidney Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Acute Kidney Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Acute Kidney Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Acute Kidney Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Acute Kidney Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Acute Kidney Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Acute Kidney Injury Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Acute Kidney Injury Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Intrinsic Acute Kidney Injury
  • Postrenal Acute Kidney Injury
  • Prerenal Acute Kidney Injury
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen AG
  • Quark Pharmaceuticals
  • Baxter International
  • LG Chem
  • Asahi Kasei Medical
  • Angion Biomedica Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acute Kidney Injury Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Acute Kidney Injury Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Acute Kidney Injury Drugs Market by Type
  6. 1.3.1 Intrinsic Acute Kidney Injury
  7. 1.3.2 Postrenal Acute Kidney Injury
  8. 1.3.3 Prerenal Acute Kidney Injury
  9. 1.3.4 Others
  10. 1.4 Global Acute Kidney Injury Drugs Market Size by Type
  11. 1.4.1 Global Acute Kidney Injury Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Acute Kidney Injury Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Acute Kidney Injury Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Acute Kidney Injury Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Acute Kidney Injury Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Acute Kidney Injury Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Acute Kidney Injury Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Acute Kidney Injury Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Acute Kidney Injury Drugs Industry Trends
  2. 2.2 Acute Kidney Injury Drugs Industry Drivers
  3. 2.3 Acute Kidney Injury Drugs Industry Opportunities and Challenges
  4. 2.4 Acute Kidney Injury Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Acute Kidney Injury Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Acute Kidney Injury Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Acute Kidney Injury Drugs Price (2021-2026)
  4. 3.4 Global Acute Kidney Injury Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Acute Kidney Injury Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Acute Kidney Injury Drugs Company, Product Type & Application
  7. 3.7 Global Acute Kidney Injury Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Acute Kidney Injury Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Acute Kidney Injury Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Acute Kidney Injury Drugs Tier 1, Tier 2, and Tier 3
4 Acute Kidney Injury Drugs Regional Status and Outlook
  1. 4.1 Global Acute Kidney Injury Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Acute Kidney Injury Drugs Historic Market Size by Region
  3. 4.2.1 Global Acute Kidney Injury Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Acute Kidney Injury Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Acute Kidney Injury Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Acute Kidney Injury Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Acute Kidney Injury Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Acute Kidney Injury Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Acute Kidney Injury Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acute Kidney Injury Drugs by Application
  1. 5.1 Acute Kidney Injury Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Acute Kidney Injury Drugs Market Size by Application
  5. 5.2.1 Global Acute Kidney Injury Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Acute Kidney Injury Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Acute Kidney Injury Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Acute Kidney Injury Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Acute Kidney Injury Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Acute Kidney Injury Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Acute Kidney Injury Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Acute Kidney Injury Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Fresenius Medical Care AG & Co. KGaA
  2. 6.1.1 Fresenius Medical Care AG & Co. KGaA Company Information
  3. 6.1.2 Fresenius Medical Care AG & Co. KGaA Business Overview
  4. 6.1.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Drugs Product Portfolio
  6. 6.1.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
  7. 6.2 B. Braun Melsungen AG
  8. 6.2.1 B. Braun Melsungen AG Company Information
  9. 6.2.2 B. Braun Melsungen AG Business Overview
  10. 6.2.3 B. Braun Melsungen AG Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 B. Braun Melsungen AG Acute Kidney Injury Drugs Product Portfolio
  12. 6.2.5 B. Braun Melsungen AG Recent Developments
  13. 6.3 Quark Pharmaceuticals
  14. 6.3.1 Quark Pharmaceuticals Company Information
  15. 6.3.2 Quark Pharmaceuticals Business Overview
  16. 6.3.3 Quark Pharmaceuticals Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Quark Pharmaceuticals Acute Kidney Injury Drugs Product Portfolio
  18. 6.3.5 Quark Pharmaceuticals Recent Developments
  19. 6.4 Baxter International
  20. 6.4.1 Baxter International Company Information
  21. 6.4.2 Baxter International Business Overview
  22. 6.4.3 Baxter International Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Baxter International Acute Kidney Injury Drugs Product Portfolio
  24. 6.4.5 Baxter International Recent Developments
  25. 6.5 LG Chem
  26. 6.5.1 LG Chem Company Information
  27. 6.5.2 LG Chem Business Overview
  28. 6.5.3 LG Chem Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LG Chem Acute Kidney Injury Drugs Product Portfolio
  30. 6.5.5 LG Chem Recent Developments
  31. 6.6 Asahi Kasei Medical
  32. 6.6.1 Asahi Kasei Medical Company Information
  33. 6.6.2 Asahi Kasei Medical Business Overview
  34. 6.6.3 Asahi Kasei Medical Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Asahi Kasei Medical Acute Kidney Injury Drugs Product Portfolio
  36. 6.6.5 Asahi Kasei Medical Recent Developments
  37. 6.7 Angion Biomedica Corp
  38. 6.7.1 Angion Biomedica Corp Company Information
  39. 6.7.2 Angion Biomedica Corp Business Overview
  40. 6.7.3 Angion Biomedica Corp Acute Kidney Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Angion Biomedica Corp Acute Kidney Injury Drugs Product Portfolio
  42. 6.7.5 Angion Biomedica Corp Recent Developments
7 North America by Country
  1. 7.1 North America Acute Kidney Injury Drugs Sales by Country
  2. 7.1.1 North America Acute Kidney Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Acute Kidney Injury Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Acute Kidney Injury Drugs Market Size by Country
  6. 7.2.1 North America Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Acute Kidney Injury Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Acute Kidney Injury Drugs Sales by Country
  2. 8.1.1 Europe Acute Kidney Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Acute Kidney Injury Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Acute Kidney Injury Drugs Market Size by Country
  6. 8.2.1 Europe Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Acute Kidney Injury Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Acute Kidney Injury Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Acute Kidney Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Acute Kidney Injury Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Acute Kidney Injury Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Acute Kidney Injury Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Acute Kidney Injury Drugs Sales by Country
  2. 10.1.1 South America Acute Kidney Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Acute Kidney Injury Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Acute Kidney Injury Drugs Market Size by Country
  6. 10.2.1 South America Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Acute Kidney Injury Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Acute Kidney Injury Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Acute Kidney Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Acute Kidney Injury Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Acute Kidney Injury Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Acute Kidney Injury Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Acute Kidney Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Acute Kidney Injury Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Acute Kidney Injury Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Acute Kidney Injury Drugs Value Chain Analysis
  2. 12.1.1 Acute Kidney Injury Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Acute Kidney Injury Drugs Production Mode & Process
  7. 12.2 Acute Kidney Injury Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Acute Kidney Injury Drugs Distributors
  10. 12.2.3 Acute Kidney Injury Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst